|
1
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer Cell. 1:49–52. 2002. View Article : Google Scholar
|
|
2
|
Sawabata N, Asamura H, Goya T, et al:
Japanese Lung Cancer Registry Study: first prospective enrollment
of a large number of surgical and nonsurgical cases in 2002. J
Thorac Oncol. 5:1369–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fidler IJ and Poste G: The ‘seed and soil’
hypothesis revisited. Lancet Oncol. 9:8082008.
|
|
5
|
Wirtz D, Konstantopoulos K and Searson PC:
The physics of cancer: the role of physical interactions and
mechanical forces in metastasis. Nat Rev Cancer. 11:512–522. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yano S, Nishioka Y, Izumi K, et al: Novel
metastasis model of human lung cancer in SCID mice depleted of NK
cells. Int J Cancer. 67:211–217. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kimura K, Nakano T, Park YB, et al:
Establishment of human osteosarcoma cell lines with high metastatic
potential to lungs and their utilities for therapeutic studies on
metastatic osteosarcoma. Clin Exp Metastasis. 19:477–485. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Francia G, Cruz-Munoz W, Man S, Xu P and
Kerbel RS: Mouse models of advanced spontaneous metastasis for
experimental therapeutics. Nat Rev Cancer. 11:135–141. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khanna C and Hunter K: Modeling metastasis
in vivo. Carcinogenesis. 26:513–523. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagamachi Y, Tani M, Shimizu K, Tsuda H,
Niitsu Y and Yokota J: Orthotopic growth and metastasis of human
non-small cell lung carcinoma cell injected into the pleural cavity
of nude mice. Cancer Lett. 127:203–209. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia D, Yan M, Wang X, et al: Development
of a highly metastatic model that reveals a crucial role of
fibronectin in lung cancer cell migration and invasion. BMC Cancer.
10:3642010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakano T, Tani M, Ishibashi Y, et al:
Biological properties and gene expression associated with
metastatic potential of human osteosarcoma. Clin Exp Metastasis.
20:665–674. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yokota J: Tumor progression and
metastasis. Carcinogenesis. 21:497–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bittner M, Meltzer P, Chen Y, et al:
Molecular classification of cutaneous malignant melanoma by gene
expression profiling. Nature. 406:536–540. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hashimoto Y, Shindo-Okada N, Tani M,
Takeuchi K, Toma H and Yokota J: Identification of genes
differentially expressed in association with metastatic potential
of K-1735 murine melanoma by messenger RNA differential display.
Cancer Res. 56:5266–5271. 1996.PubMed/NCBI
|
|
16
|
Clark EA, Golub TR, Lander ES and Hynes
RO: Genomic analysis of metastasis reveals an essential role for
RhoC. Nature. 406:532–535. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashimoto Y, Shindo-Okada N, Tani M, et
al: Expression of the Elm1 gene, a novel gene of the CCN
(connective tissue growth factor, Cyr61/Cef10, and neuroblastoma
overexpressed gene) family, suppresses in vivo tumor growth and
metastasis of K-1735 murine melanoma cells. J Exp Med. 187:289–296.
1998. View Article : Google Scholar
|
|
18
|
Raynaud CM, Mercier O, Dartevelle P, et
al: Expression of chemokine receptor CCR6 as a molecular
determinant of adrenal metastatic relapse in patients with primary
lung cancer. Clin Lung Cancer. 11:187–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bjorge JD, Pang AS, Funnell M, et al:
Simultaneous siRNA targeting of Src and downstream signaling
molecules inhibit tumor formation and metastasis of a human model
breast cancer cell line. PLoS One. 6:e193092011. View Article : Google Scholar
|
|
20
|
Bulk E, Sargin B, Krug U, et al: S100A2
induces metastasis in non-small cell lung cancer. Clin Cancer Res.
15:22–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoffman RM: Orthotopic metastatic mouse
models for anticancer drug discovery and evaluation: a bridge to
the clinic. Invest New Drugs. 17:343–359. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sawabata N, Miyaoka E, Asamura H, et al:
Japanese lung cancer registry study of 11,663 surgical cases in
2004: demographic and prognosis changes over decade. J Thorac
Oncol. 6:1229–1235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yano S, Shinohara H, Herbst RS, et al:
Expression of vascular endothelial growth factor is necessary but
not sufficient for production and growth of brain metastasis.
Cancer Res. 60:4959–4967. 2000.PubMed/NCBI
|
|
24
|
Arifin M, Tanimoto K, Putra AC, Hiyama E,
Nishiyama M and Hiyama K: Carcinogenesis and cellular
immortalization without persistent inactivation of p16/Rb pathway
in lung cancer. Int J Oncol. 36:1217–1227. 2010.PubMed/NCBI
|
|
25
|
Noro R, Gemma A, Kosaihira S, et al:
Gefitinib (IRESSA) sensitive lung cancer cell lines show
phosphorylation of Akt without ligand stimulation. BMC Cancer.
6:2772006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lynch TJ, Bell DW, Sordella R, et al:
Activating mutations in the epidermal growth factor receptor
underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yeh HH, Ogawa K, Balatoni J, et al:
Molecular imaging of active mutant L858R EGF receptor (EGFR)
kinase-expressing non-small cell lung carcinomas using PET/CT. Proc
Natl Acad Sci USA. 108:1603–1608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee H, Deng J, Kujawski M, et al:
STAT3-induced S1PR1 expression is crucial for persistent STAT3
activation in tumors. Nat Med. 16:1421–1428. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Spiegel S and Milstien S: The outs and the
ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol.
11:403–415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Visentin B, Vekich JA, Sibbald BJ, et al:
Validation of an anti-sphingosine-1-phosphate antibody as a
potential therapeutic in reducing growth, invasion, and
angiogenesis in multiple tumor lineages. Cancer Cell. 9:225–238.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chae SS, Paik JH, Furneaux H and Hla T:
Requirement for sphingosine 1-phosphate receptor-1 in tumor
angiogenesis demonstrated by in vivo RNA interference. J Clin
Invest. 114:1082–1089. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Metodieva SN, Nikolova DN, Cherneva RV,
Dimova II, Petrov DB and Toncheva DI: Expression analysis of
angiogenesis-related genes in Bulgarian patients with early-stage
non-small cell lung cancer. Tumori. 97:86–94. 2011.PubMed/NCBI
|
|
33
|
Yamaguchi H, Kitayama J, Takuwa N, et al:
Sphingosine-1-phosphate receptor subtype-specific positive and
negative regulation of Rac and haematogenous metastasis of melanoma
cells. Biochem J. 374:715–722. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takuwa Y: Subtype-specific differential
regulation of Rho family G proteins and cell migration by the Edg
family sphingosine-1-phosphate receptors. Biochim Biophys Acta.
1582:112–120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shukla D, Liu J, Blaiklock P, et al: A
novel role for 3-O-sulfated heparan sulfate in herpes simplex virus
1 entry. Cell. 99:13–22. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arvatz G, Shafat I, Levy-Adam F, Ilan N
and Vlodavsky I: The heparanase system and tumor metastasis: is
heparanase the seed and soil? Cancer Metastasis Rev. 30:253–268.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang M, Chen L, Wang S and Wang T: Rab7:
roles in membrane trafficking and disease. Biosci Rep. 29:193–209.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Frasa MA, Maximiano FC, Smolarczyk K, et
al: Armus is a Rac1 effector that inactivates Rab7 and regulates
E-cadherin degradation. Curr Biol. 20:198–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Steffan JJ, Williams BC, Welbourne T and
Cardelli JA: HGF-induced invasion by prostate tumor cells requires
anterograde lysosome trafficking and activity of
Na+-H+ exchangers. J Cell Sci. 123:1151–1159.
2010. View Article : Google Scholar : PubMed/NCBI
|
